Helen Clark, the Partnership for Maternal, Newborn and Child Health board chairperson. FILE PHOTO | NMG
By BERNADINE MUTANU
Former New Zealand Prime
Minister Helen Clark was among the high-profile people at the recent
International Conference on Population and Development (ICPD) in Nairobi
where she represented
the Partnership for Maternal, Newborn and Child Health (PMNCH), an alliance of more than 1,000 organisations backed by the World Health Organisation (WHO).
the Partnership for Maternal, Newborn and Child Health (PMNCH), an alliance of more than 1,000 organisations backed by the World Health Organisation (WHO).
As the
chairperson of the PMNCH board, Ms Clark has been particularly vocal in
challenging world leaders and governments to prioritise sexual and
reproductive health and rights of women, children and adolescents at the
centre of policies such as universal health coverage.
She
spoke to the Business Daily about the progress and challenges of this
campaign, including PMNCH's stand at the Nairobi Summit.
WHAT WAS YOUR STAND ON SEXUAL AND REPRODUCTIVE HEALTH AND RIGHTS (SRHR) AT THE NAIROBI SUMMIT?
The
Nairobi Summit took place at a time of critical importance for sexual
and reproductive health and rights. Ideologically driven forces are
seeking to roll back hard-won gains, to slash funding for essential
services, and to remove references to these services and rights from
international agreements. So, my stand on SRHR during the Nairobi Summit
has been that we need to be bold. We have made progress since Cairo in
1994 — but that progress still falls short for many women and girls —
and that can be a life and death matter.
IN FEBRUARY, THERE WAS A CALL TO ACTION ON SEXUAL AND REPRODUCTIVE HEALTH AND RIGHTS (SRHR), HOW WAS IT RECEIVED?
The
response to the call to action has been very positive — over 300
organisations to date have signed on to it. But our work is far from
done. In September, the UN General Assembly Political Declaration on UHC
included some language on SRHR, but a group of countries disassociated
themselves from that part of the text. So, clearly more dialogue is
needed to make the case for SRHR in UHC in all countries. Our advocacy
efforts also need to target Ministers of Finance and Heads of State to
make the case for how SRHR contributes to healthy people and healthy
economies.
WHAT IS THE STATE OF SRHR, ESPECIALLY IN SUB-SAHARAN AFRICA?
There
has been progress on SRHR, but a lot remains to be done. Unfortunately,
progress has been slower in Sub-Saharan Africa than elsewhere. For
example, according to the latest UN figures, Sub-Saharan Africa accounts
for roughly two thirds of maternal deaths worldwide, and rates in the
region are decreasing at a slower pace than they are elsewhere.
The
unmet need for contraception in the region also remains high. According
to the Guttmacher-Lancet Commission, in 2017 214 million women of
reproductive age in developing regions had an unmet need for modern
contraception. Forty-two per cent of all women of reproductive age in
developing regions were using modern contraceptive methods, ranging from
as low as 22 per cent in Africa to 52 per cent in Latin America and the
Caribbean.
When considering SRHR, we must also
consider reproductive cancers. According to WHO, in Africa, 34 out of
every 100,000 women are diagnosed with cervical cancer each year and 23
out of every 100, 000 women die from cervical cancer every year. Compare
those figures with those in North America where seven out of every
100,000 women are diagnosed with cervical cancer each year and three out
of every 100,000 women die of the disease each year. In Africa, most of
the women with cervical cancer are diagnosed when the cancer is at an
advanced stage which tragically is associated with poor outcomes. That
is why the roll out of the human papilloma virus (HPV) vaccine is so
important in preventing infection by common strains of HPV which cause
cervical cancer. Just last month, Kenya joined an increasing number of
African countries in introducing the HPV vaccine against cervical cancer
into its routine immunisation schedule.
WHAT ARE SOME OF THE CHALLENGES IN ATTAINING UNIVERSAL HEALTH COVERAGE?
When
we talk about UHC, we often talk about three dimensions — what services
are included, who has access to them, and at what cost. So, we can
frame the challenges around those three dimensions. Funding is always a
challenge, but what is most important in that respect is political will.
We need visionary leaders who put people at the centre of policy and
who understand that investing in health –and prioritising the needs of
women, children, and adolescents – is the soundest investment they can
make.
WHAT ARE THE GAPS IN THE COVERAGE OF SRHR
INTERVENTIONS ESPECIALLY IN DEVELOPING NATIONS? WHAT CAN BE DONE TO
IMPROVE THE SITUATION?
Overall, progress has
been uneven, and there are gaps across most, if not all, SRHR
interventions in low- and middle-income countries. What can be done?
Again, political leadership – at the highest level – which prioritises
SRHR is essential. Increased investment in the quality and coverage of
SRHR services is required. For low-income countries which rely heavily
on official development assistance, donors need to step up their funding
for these essential services in order to uphold the rights and dignity
of women and young people.
No comments :
Post a Comment